Evidence map›Paper›PMID 36465614›Full record

ArticleFrontiers in endocrinology2022

Potential genetic biomarkers predict adverse pregnancy outcome during early and mid-pregnancy in women with systemic lupus erythematosus.

Yu Deng, Yiran Zhou, Jiangcheng Shi, Junting Yang, Hong Huang, Muqiu Zhang, Shuxian Wang, Qian Ma, Yingnan Liu, Boya Li and 2 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in endocrinology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Application of Machine Learning Models in Systemic Lupus Erythematosus.International journal of molecular sciences · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Yu DengDepartment of Obstetrics and Gynecology, Peking University First Hospital, Beijing, China.
Yiran ZhouDepartment of Medicinal Chemistry, School of Pharmaceutical Sciences, Peking University, Beijing, China.
Jiangcheng ShiSchool of Life Sciences, Tiangong University, Tianjin, China.
Junting YangDepartment of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing, China.
Hong HuangDepartment of Rheumatology and Clinical Immunology, Peking University First Hospital, Beijing, China.
Muqiu ZhangDepartment of Obstetrics and Gynecology, Peking University First Hospital, Beijing, China.
Shuxian WangDepartment of Obstetrics and Gynecology, Peking University First Hospital, Beijing, China.
Qian MaDepartment of Clinical Laboratory, Peking University First Hospital, Beijing, China.
Yingnan LiuDepartment of Obstetrics and Gynecology, Peking University First Hospital, Beijing, China.
Boya LiDepartment of Obstetrics and Gynecology, Peking University First Hospital, Beijing, China.
Jie YanDepartment of Obstetrics and Gynecology, Peking University First Hospital, Beijing, China.
Huixia YangDepartment of Obstetrics and Gynecology, Peking University First Hospital, Beijing, China.
Peking University First Hospital · CNPeking University · CNTianjin Polytechnic University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Effectively predicting the risk of adverse pregnancy outcome (APO) in women with systemic lupus erythematosus (SLE) during early and mid-pregnancy is a challenge. This study was aimed to identify potential markers for early prediction of APO risk in women with SLE. Methods: The GSE108497 gene expression dataset containing 120 samples (36 patients, 84 controls) was downloaded from the Gene Expression Omnibus database. Weighted gene co-expression network analysis (WGCNA) was performed, and differentially expressed genes (DEGs) were screened to define candidate APO marker genes. Next, three individual machine learning methods, random forest, support vector machine-recursive feature elimination, and least absolute shrinkage and selection operator, were combined to identify feature genes from the APO candidate set. The predictive performance of feature genes for APO risk was assessed using area under the receiver operating characteristic curve (AUC) and calibration curves. The potential functions of these feature genes were finally analyzed by conventional gene set enrichment analysis and CIBERSORT algorithm analysis. Results: We identified 321 significantly up-regulated genes and 307 down-regulated genes between patients and controls, along with 181 potential functionally associated genes in the WGCNA analysis. By integrating these results, we revealed 70 APO candidate genes. Three feature genes, Conclusions: Our preliminary findings suggested that

Indexed as

Lupus Erythematosus, SystemicPregnancy ComplicationsPregnancy OutcomeArea Under CurveFemaleGenetic MarkersHumansNerve Tissue ProteinsPregnancyReceptors, Lysophosphatidic AcidRNA, Long NoncodingROC CurveGenetic MarkersLPAR4 protein, humanNerve Tissue ProteinsReceptors, Lysophosphatidic AcidRNA, Long Noncodingadverse pregnancy outcomebioinformatic analysisearly and mid-pregnancymachine learningsystemic lupus erythematosus

Identifiers

PMID36465614
PMCPMC9708709
OpenAlexW4309317627

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.